Abstract
Comparative evaluation of six commercial rubella virus antibody kits is described. A set of serum samples skewed toward nonreactive and low-positive rubella antibody levels was used because the goal of an immunity screening test is the detection of susceptible individuals. The M. A. Bioproducts Rubastat and the Hynson, Westcott and Dunning Rubascan were superior in achieving high sensitivity, specificity, and reproducibility. They also were the easiest and fastest tests to perform, and they require equipment available in most laboratories.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Castellano G. A., Madden D. L., Hazzard G. T., Cleghorn C. S., Vails D. V., Ley A. C., Tzan N. R., Sever J. L. Evaluation of commercially available diagnostic test kits for rubella. J Infect Dis. 1981 Apr;143(4):578–584. doi: 10.1093/infdis/143.4.578. [DOI] [PubMed] [Google Scholar]
- Truant A. L., Barksdale B. L., Huber T. W., Elliott L. B. Comparison of an enzyme-linked immunosorbent assay with indirect hemagglutination and hemagglutination inhibition for determination of rubella virus antibody: evaluation of immune status with commercial reagents in a clinical laboratory. J Clin Microbiol. 1983 Jan;17(1):106–108. doi: 10.1128/jcm.17.1.106-108.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Weissfeld A. S., Sonnenwirth A. C. New latex agglutination test for rapid determination of rubella immune status. J Clin Microbiol. 1982 Nov;16(5):971–972. doi: 10.1128/jcm.16.5.971-972.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]